Proteomic Profiling of Pulmonary Function and Cardiovascular Disease Risk in the Atherosclerosis Risk in Communities Study
Journal of the American Heart Association · 2026
DOI: 10.1161/jaha.125.043281 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Yura Lee und 10 weiteren Autor:innen. Beteiligte Einrichtung: Human Genetics Center, School of Public Health The University of Texas Health Science Center at Houston TX USA. Hauptthemen laut MEDLINE: Lung, Proteomics, Pulmonary Disease, Chronic Obstructive. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NLM NIH HHS.
Abstract (Originalsprache)
Background
Pulmonary function is linked to cardiovascular disease risk; however, the underlying mechanisms remain unclear. We aimed to identify protein biomarkers associated with pulmonary function and examine their impact on incident chronic obstructive pulmonary disease, coronary heart disease, heart failure, and all‐cause mortality.
Methods
Data from White and Black Americans in the Atherosclerosis Risk in Communities study (visit 2: N=11 354, mean age=57 years; visit 5: N=3517, mean age=75 years), a prospective cohort, were analyzed. Linear regression assessed associations between protein levels and pulmonary function measures, including forced expiratory volume in 1 second and forced vital capacity. The impact of the identified proteins on incident chronic obstructive pulmonary disease, coronary heart disease, heart failure, and mortality was estimated using logistic regression and Cox proportional hazards models. Pathway enrichment and Mendelian randomization explored underlying biological functions and causal effects.
Results
Of 4766 proteins analyzed, 364 were cross‐sectionally associated with forced expiratory volume in 1 second (and forced vital capacity (false discovery rate
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Human Genetics Center, School of Public Health The University of Texas Health Science Center at Houston TX USA.
- Department of Epidemiology, School of Public Health The University of Texas Health Science Center at Houston TX USA.
- Department of Molecular and Human Genetics Baylor College of Medicine Houston TX USA.
- Department of Epidemiology, Bloomberg School of Public Health Johns Hopkins University Baltimore MD USA.
- Department of Internal Medicine and Division of Cardiology The University of Texas Southwestern Medical Center Dallas TX USA.
- Center for Precision Health, School of Biomedical Informatics The University of Texas Health Science Center at Houston TX USA.
ORCID-Profile: Yura Lee, Astrid M Manuel, Christine Ladd-Acosta, Alanna C Morrison, Kari E North, Eric Boerwinkle, Amil M Shah, Zhongming Zhao, Stephanie J London, Bing Yu
Förderung
- NHLBI NIH HHS
- NLM NIH HHS
Zitieren
APA
Lee, Y., Manuel, A. M., Nguyen, N. Q. H., Ladd-Acosta, C., Morrison, A. C., North, K. E., Boerwinkle, E., Shah, A. M., Zhao, Z., London, S. J., & Yu, B. (2026). Proteomic Profiling of Pulmonary Function and Cardiovascular Disease Risk in the Atherosclerosis Risk in Communities Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.043281
Vancouver
Lee Y, Manuel AM, Nguyen NQH, Ladd-Acosta C, Morrison AC, North KE, et al. Proteomic Profiling of Pulmonary Function and Cardiovascular Disease Risk in the Atherosclerosis Risk in Communities Study. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.043281
BibTeX
@article{Lee2026,
author = {Lee, Yura and Manuel, Astrid M and Nguyen, Ngoc Quynh H and Ladd-Acosta, Christine and Morrison, Alanna C and North, Kari E and Boerwinkle, Eric and Shah, Amil M and Zhao, Zhongming and London, Stephanie J and Yu, Bing},
title = {Proteomic Profiling of Pulmonary Function and Cardiovascular Disease Risk in the Atherosclerosis Risk in Communities Study},
journal = {Journal of the American Heart Association},
year = {2026},
doi = {10.1161/jaha.125.043281}
}
EUVIMED